External imaging techniques for quantitation of distribution of I-131 F (ab ′)2 fragments of monoclonal antibody in humans

Authors:
  • NHNancy D. Hammond
    Nancy D. Hammond
  • PMPhilip J. Moldofsky
    Philip J. Moldofsky
  • MBMichelle R. Beardsley
    Michelle R. Beardsley
  • CMCharles B. Mulhern
    Charles B. Mulhern

Abstract
Noninvasive, external counting techniques were employed for quantitation of 131I F(ab'')2 fragment of mouse monoclonal antibody localized in metastatic lesions and surrounding liver tissue in humans. This method utilizes counts from diametrically opposed views of tumor deposits and surrounding normal tissue. Corrections were made for patient attenuation, lesion size, and surrounding tissue activity. The validity of this method was evaluated using a fillable, tissue-equivalent organ-scanning phantom with organs and tumors of selected size. Less than 10% error was found in quantitation of various activites 131I in a 4-cm-diam lesion. Tumor activity ranged from 0.001-0.018% of administered dose per cm3 of tissue compared with 0.00012%-0.0023% per cm3 of liver. In addition, the vascular clearance of total 131I and protein-bound 131I followed a 2-compartment model with mean half lives of 3.8 and 21.4 h for total 131I and 3.9 and 24.4 h for protein-bound 131I.